August 3, 2011
By:Bill Gillette
Recently published study results suggest that distinct antigen-specific T-cell responses may play a role in the pathogenesis of psoriasis and atopic eczema, HealthDay News reports.
 |
June 15, 2011
By:Bill Gillette
Brief individual counseling sessions led to significant improvement for physicians and other healthcare professionals suffering from occupational hand eczema, InternalMedicineNews.com reports.
|
April 13, 2011
By:Bill Gillette
Childhood eczema can have a detrimental effect not only on children who suffer from the disorder, but also for their families, Medical New Today reports.
|
March 23, 2011
By:Bill Gillette
Children who have more severe atopic dermatitis, or eczema, are less likely to outgrow allergies to milk or eggs, Medical News Today reports.
|
January 1, 2011
By:Lisa Samalonis
Evidence-based treatment options for moderate-to-severe pediatric atopic dermatitis and psoriasis are severely limited, according to specialists in the field, leading to the creation of a national collaborative by several pediatric dermatologists.
|
October 5, 2010
By:Bill Gillette
A recent study conducted by the Center for Connected Health suggests that text messages are an effective tool for improving patient compliance with treatment and self-care, PRNewswire reports.
|
February 1, 2010
By:Angela Dyer
Headed for Miami for the big dermatology meeting in March? We’ve already checked out the scene for you! Take a look through our City Guide to find the best in dining, sights to see, shopping and nightlife, plus handy information on how to get around.
|
September 11, 2009
By:John Jesitus
Las Vegas — A skin barrier protection cream (Tetrix, Coria Laboratories) appears to reduce exposure to skin allergens and irritants and decrease symptoms of eczematous dermatitis, according to James Q. Del Rosso, D.O., dermatology residency director, Valley Hospital Medical Center, Las Vegas. |
August 31, 2009
By:Ilya Petrou, M.D.
Sheffield, England — New research data demonstrates that mild, moderate and potent strengths of topical corticosteroids (TCS) cause a thinning of the stratum corneum, particularly when applied for longer periods of time, whereas topical calcineurin inhibitors show no negative change in the integrity of the skin barrier. |
| 
Practice Tools
